Patent details

EP2905033 Title: Monodisperse PEGylated naloxol compositions

Basic Information

Publication number:
EP2905033
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP151561677
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Monodisperse PEGylated naloxol compositions
French Title of Invention:
Compositions monodisperses contenant du naloxol PEGylé
German Title of Invention:
Monodisperse PEGylierte Naloxol-enthaltende Zusammensetzungen
SPC Number:

Dates

Filing date:
16/12/2004
Grant date:
02/09/2020
EP Publication Date:
12/08/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/09/2020
EP B1 Publication Date:
02/09/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
16/12/2020
Expiration date:
16/12/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/08/2020
 
 

Name:
Nektar Therapeutics
Address:
455 Mission Bay Boulevard South, Suite 100, San Francisco, CA 94185, United States (US)

Inventor

1

Name:
Zhao, Xuan
Address:
China (CN)

2

Name:
Cheng, Lin
Address:
United States (US)

3

Name:
Viegas, Tracey X.
Address:
United States (US)

4

Name:
Bentley, Michael D
Address:
United States (US)

5

Name:
Goodin, Richard R.
Address:
United States (US)

Priority

Priority Number:
530122 P
Priority Date:
16/12/2003
Priority Country:
United States (US)

Classification

IPC classification:
C08G 65/08; A61K 47/60;

Publication

European Patent Bulletin

Issue number:
202036
Publication date:
02/09/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages